Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
S&W Seed | SANW | Nov 22, 2024 | 6.57 | +26.35 |
SAB Biotherapeutics | SABS | Nov 22, 2024 | 3.13 | +1.95 |
Saba Capital | BRW | Nov 22, 2024 | 7.61 | +0.26 |
Saba Capital Income & Opportunities Fund II | SABA | Nov 22, 2024 | 8.69 | -0.11 |
Sabine Royalty Trust Unit | SBR | Nov 22, 2024 | 63.07 | +0.62 |
Sable Offshore | SOC | Nov 22, 2024 | 24.08 | +4.60 |
Sabra Health Care REIT | SBRA | Nov 22, 2024 | 18.41 | +0.33 |
Sabre | SABR | Nov 22, 2024 | 3.73 | +1.63 |
Sachem Capital | SACH | Nov 22, 2024 | 1.59 | 0.00 |
Sachem Capital A Pref | SACH-A | Nov 22, 2024 | 19.14 | -2.94 |
Sacks Parente Golf | SPGC | Nov 22, 2024 | 1.59 | -1.13 |
Sadot Group | SDOT | Nov 22, 2024 | 3.36 | -4.82 |
Safe & Green Holdings | SGBX | Nov 22, 2024 | 0.52 | +1.75 |
Safe And Green Development | SGD | Nov 22, 2024 | 1.90 | +6.15 |
Safe Bulkers | SB | Nov 22, 2024 | 4.17 | +1.21 |
Safe Bulkers Pref C | SB-C | Nov 22, 2024 | 25.51 | 0.00 |
Safe Bulkers Pref D | SB-D | Nov 22, 2024 | 25.95 | +0.73 |
Safe Pro Group | SPAI | Nov 22, 2024 | 4.57 | 0.00 |
Safehold | SAFE | Nov 22, 2024 | 20.81 | +1.71 |
Safety Insurance Group | SAFT | Nov 22, 2024 | 84.86 | +0.11 |
Safety Shot | SHOT | Nov 22, 2024 | 0.83 | -5.11 |
SAG Holdings Limited - Ordinary Shares | SAG | Nov 22, 2024 | 2.74 | 0.00 |
Saga Communications A | SGA | Nov 22, 2024 | 13.19 | +4.52 |
Sage Therapeutics | SAGE | Nov 22, 2024 | 5.17 | +6.60 |
Sagimet Biosciences | SGMT | Nov 22, 2024 | 4.76 | +5.78 |
SAI.TECH Global | SAI | Nov 22, 2024 | 0.75 | 0.00 |
Saia | SAIA | Nov 22, 2024 | 541.69 | -1.37 |
SAIHEAT A | SAIH | Nov 22, 2024 | 1.11 | 0.00 |
Salarius Pharmaceuticals | SLRX | Nov 22, 2024 | 1.37 | -6.16 |
Salesforce | CRM | Nov 22, 2024 | 342.02 | +1.86 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.